GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » Li Kang Biomedical Co Ltd (ROCO:6242) » Definitions » EV-to-Revenue

Li Kang Biomedical Co (ROCO:6242) EV-to-Revenue : 1.97 (As of May. 19, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Li Kang Biomedical Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Li Kang Biomedical Co's enterprise value is NT$1,176.5 Mil. Li Kang Biomedical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was NT$596.8 Mil. Therefore, Li Kang Biomedical Co's EV-to-Revenue for today is 1.97.

The historical rank and industry rank for Li Kang Biomedical Co's EV-to-Revenue or its related term are showing as below:

ROCO:6242' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.38   Med: 1.89   Max: 4.59
Current: 1.97

During the past 13 years, the highest EV-to-Revenue of Li Kang Biomedical Co was 4.59. The lowest was 0.38. And the median was 1.89.

ROCO:6242's EV-to-Revenue is ranked better than
55.85% of 829 companies
in the Travel & Leisure industry
Industry Median: 2.26 vs ROCO:6242: 1.97

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-19), Li Kang Biomedical Co's stock price is NT$50.40. Li Kang Biomedical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was NT$21.28. Therefore, Li Kang Biomedical Co's PS Ratio for today is 2.37.


Li Kang Biomedical Co EV-to-Revenue Historical Data

The historical data trend for Li Kang Biomedical Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Li Kang Biomedical Co EV-to-Revenue Chart

Li Kang Biomedical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.56 1.44 1.91 1.56 2.25

Li Kang Biomedical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.58 2.12 2.17 2.25 2.16

Competitive Comparison of Li Kang Biomedical Co's EV-to-Revenue

For the Travel Services subindustry, Li Kang Biomedical Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Li Kang Biomedical Co's EV-to-Revenue Distribution in the Travel & Leisure Industry

For the Travel & Leisure industry and Consumer Cyclical sector, Li Kang Biomedical Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Li Kang Biomedical Co's EV-to-Revenue falls into.



Li Kang Biomedical Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Li Kang Biomedical Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1176.541/596.801
=1.97

Li Kang Biomedical Co's current Enterprise Value is NT$1,176.5 Mil.
Li Kang Biomedical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$596.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Li Kang Biomedical Co  (ROCO:6242) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Li Kang Biomedical Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=50.40/21.279
=2.37

Li Kang Biomedical Co's share price for today is NT$50.40.
Li Kang Biomedical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$21.28.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Li Kang Biomedical Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Li Kang Biomedical Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Li Kang Biomedical Co (ROCO:6242) Business Description

Traded in Other Exchanges
N/A
Address
No.29, Huangong Road, Yongkang District, Taipei City, TWN, 71041
Li Kang Biomedical Co Ltd is a Taiwan based company engages in tourism factory businesses, telemarketing, as well as the manufacturing and sales of cosmetics and hygienic drinks.

Li Kang Biomedical Co (ROCO:6242) Headlines

No Headlines